METRONIDAZOLE — all Canadian products
35 DINs
21 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is METRONIDAZOLE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02248562 | APO-METRONIDAZOLE | APOTEX INC | Capsule | Oral | METRONIDAZOLE 500 MG | Marketed | |
| 00545066 | APO-METRONIDAZOLE TABLETS | APOTEX INC | Tablet | Oral | METRONIDAZOLE 250 MG | Marketed | |
| 02470284 | AURO-METRONIDAZOLE | AURO PHARMA INC | Capsule | Oral | METRONIDAZOLE 500 MG | Marketed | |
| 02499819 | ERADIA | VIRBAC AH, INC. | Suspension | Oral | METRONIDAZOLE 125 MG | Marketed | |
| 01926829 | FLAGYSTATIN | SANOFI-AVENTIS CANADA INC | Ovule | Vaginal | METRONIDAZOLE 500 MG; NYSTATIN 100000 UNIT | Marketed | |
| 02571129 | JAMP METRONIDAZOLE GEL | JAMP PHARMA CORPORATION | Gel | Topical | METRONIDAZOLE 0.75 % | Approved | |
| 02519755 | M-METRONIDAZOLE | MANTRA PHARMA INC | Capsule | Oral | METRONIDAZOLE 500 MG | Marketed | |
| 02491370 | MAR-METRONIDAZOLE | MARCAN PHARMACEUTICALS INC | Capsule | Oral | METRONIDAZOLE 500 MG | Approved | |
| 02092832 | METROGEL 0.75% | GALDERMA CANADA INC. | Gel | Topical | METRONIDAZOLE 0.75 % | Marketed | |
| 02297809 | METROGEL 1% | GALDERMA CANADA INC. | Gel | Topical | METRONIDAZOLE 1 % | Marketed | |
| 02534592 | METRONIDAZOLE | SANIS HEALTH INC | Capsule | Oral | METRONIDAZOLE 500 MG | Marketed | |
| 02518767 | METRONIDAZOLE | JAMP PHARMA CORPORATION | Capsule | Oral | METRONIDAZOLE 500 MG | Marketed | |
| 00870420 | METRONIDAZOLE INJECTION, USP | BAXTER CORPORATION | Solution | Intravenous | METRONIDAZOLE 5 MG | Marketed | |
| 02535807 | MINT-METRONIDAZOLE | MINT PHARMACEUTICALS INC | Tablet | Oral | METRONIDAZOLE 250 MG | Marketed | |
| 02125226 | NIDAGEL | BAUSCH HEALTH, CANADA INC. | Gel | Vaginal | METRONIDAZOLE 0.75 % | Marketed | |
| 02156091 | NORITATE | BAUSCH HEALTH, CANADA INC. | Cream | Topical | METRONIDAZOLE 1 % | Marketed | |
| 00783137 | PMS-METRONIDAZOLE | PHARMASCIENCE INC | Capsule | Oral | METRONIDAZOLE 500 MG | Marketed | |
| 02564343 | PMS-METRONIDAZOLE GEL | PHARMASCIENCE INC | Gel | Topical | METRONIDAZOLE 0.75 % | Approved | |
| 02564351 | PMS-METRONIDAZOLE GEL | PHARMASCIENCE INC | Gel | Topical | METRONIDAZOLE 1 % | Approved | |
| 02567342 | TARO-METRONIDAZOLE GEL | TARO PHARMACEUTICALS INC | Gel | Topical | METRONIDAZOLE 0.75 % | Approved | |
| 02567350 | TARO-METRONIDAZOLE GEL | TARO PHARMACEUTICALS INC | Gel | Topical | METRONIDAZOLE 1 % | Approved | |
| 02406470 | APO-METRONIDAZOLE | APOTEX INC | Tablet | Oral | METRONIDAZOLE 250 MG | Cancelled Pre Market | |
| 02406489 | APO-METRONIDAZOLE | APOTEX INC | Capsule | Oral | METRONIDAZOLE 500 MG | Cancelled Pre Market | |
| 01926853 | FLAGYL | SANOFI-AVENTIS CANADA INC | Capsule | Oral | METRONIDAZOLE 500 MG | Cancelled Pre Market | |
| 01926861 | FLAGYL | SANOFI-AVENTIS CANADA INC | Cream | Vaginal | METRONIDAZOLE 10 % | Cancelled Post Market | |
| 01926888 | FLAGYL 500 500MG | AVENTIS PHARMA INC | Suppository | Vaginal | METRONIDAZOLE 500 MG | Cancelled Post Market | |
| 01926837 | FLAGYSTATIN | AVENTIS PHARMA INC | Suppository | Vaginal | METRONIDAZOLE 500 MG; NYSTATIN 100000 UNIT | Cancelled Post Market | |
| 01926845 | FLAGYSTATIN | SANOFI-AVENTIS CANADA INC | Cream | Vaginal | METRONIDAZOLE 500 MG; NYSTATIN 100000 UNIT | Cancelled Post Market | |
| 02244405 | FLORAZOLE ER | FERRING INC | Tablet (Extended-Release) | Oral | METRONIDAZOLE 750 MG | Cancelled Post Market | |
| 02248206 | METROLOTION | GALDERMA CANADA INC. | Lotion | Topical | METRONIDAZOLE 0.75 % | Cancelled Post Market | |
| 00649074 | METRONIDAZOLE INJECTION USP | PFIZER CANADA ULC | Solution | Intravenous | METRONIDAZOLE 5 MG | Cancelled Post Market | |
| 00420409 | METRONIDAZOLE TAB 250MG | PRO DOC LIMITEE | Tablet | Oral | METRONIDAZOLE 250 MG | Cancelled Post Market | |
| 00021555 | NOVO-NIDAZOL TAB 250MG | NOVOPHARM LIMITED | Tablet | Oral | METRONIDAZOLE 250 MG | Cancelled Post Market | |
| 00584339 | PMS-METRONIDAZOLE 250MG/TAB | PHARMASCIENCE INC | Tablet | Oral | METRONIDAZOLE 250 MG | Cancelled Post Market | |
| 02242919 | ROSASOL | GLAXOSMITHKLINE INC | Cream | Topical | METRONIDAZOLE 1.0 %; OCTINOXATE 7.5 %; AVOBENZONE 2.0 % | Cancelled Post Market |
Browse other molecules: